Examining the effects of a Mediterranean diet on Parkinson's Disease
Official title: Canadian Parkinson's Microbiome Initiative: A Pilot Phase 2 Feasibility Randomized Controlled Trial of the MIND Diet in Parkinson's Disease
Run by University of British Columbia · NCT06207136 · Data updated 2026-11-12
This study is trying out a Mediterranean diet for people with Parkinson's Disease to see if it helps improve their symptoms and overall health compared to a regular diet.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 80 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of British Columbia Academic / other |
| Locations | 1 site (Vancouver, British Columbia) |
| Status | Recruiting |
| Started | December 3, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT06207136 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 40-80 with a clinical diagnosis of Parkinson's Disease who are cognitively stable and can commit to the study's requirements.
✕Probably not a fit
Patients with atypical parkinsonism, significant medical conditions, or those unable to participate fully in the nutrition intervention may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to assess the feasibility and effects of an 18-month Mediterranean-style diet intervention compared to a standard diet in individuals living with Parkinson's Disease who do not have dementia. Participants will be randomly assigned to either diet group and will receive virtual nutrition coaching and cooking classes, along with regular in-person assessments at the University of British Columbia. The study will monitor changes in gut microbiome and Parkinson's symptoms, utilizing wearable devices to track physical activity and lifestyle factors throughout the intervention period.
Why it matters
Potential benefit: If successful, this study could provide insights into dietary interventions that may improve symptoms and quality of life for patients with Parkinson's Disease.
How similar studies have gone: While there is existing research linking Mediterranean diets to reduced risk and mortality in Parkinson's Disease, this specific intervention is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Eligible if the person living with Parkinson's has/is: 1. a clinical diagnosis of PD, 2. cognitively stable (no clinical dementia), 3. between 40-80 years old, 4. able to travel to UBC for 6 onsite visits over 18 months, 5. sufficient English proficiency (coaching and cooking classes are in English only), 6. on a stable dopaminergic medication for at least one month before baseline, 7. computer and internet access at home, and can be available via video link for at least 80% of the study sessions. Exclusion Criteria: Not eligible, if person has/is: 1. a diagnosis of atypical parkinsonism, 2. medical or psychiatric conditions that would prevent full participation in the nutrition intervention (such as food allergies), significant dysphagia, diabetes on insulin, anti-coagulation on warfarin, and inflammatory bowel disease, 3. clinical dementia, 4. unable to complete questionnaires or understand study instructions, 5. using of immunomodulatory agents, 6. used Probiotics in the last 4 weeks prior to study start, 7. used Antibiotics in the last 3 months prior to study start, 8. contraindications for MRI.
Where it's running
-
UBC Pacific Parkinson's Research Centre
Vancouver, British Columbia, Canada Recruiting
Study contacts
- Principal investigator: Silke Appel-Cresswell, MD, FRCPC — University of British Columbia
- Study coordinator: Annie Kuan
- Email: annie.kuan@ubc.ca
- Phone: 604-827-0576
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
Overnight Temperature Regulation to Test Gut Health, Inflammation, and Circadian Rhythms
This study tests whether two weeks of using the Eight Sleep Pod at night can improve gut bacteria balance, lower inflammation, and strengthen daily temperature and blood pressure rhythms in postmenopausal women and age-matched men with poor sleep.
-
Egg intake and gut health, HDL, and immune markers in adults
This study tests whether daily egg whites or whole eggs affect gut microbiome, HDL function, metabolism, and immune profiles in adults with a range of BMIs.
-
Tiny Tummies: Milk vs. Oat Milk for Toddlers
This 12‑month randomized study will test whether 12‑month‑old toddlers who drink daily cow’s milk dairy vs. oat milk dairy have better growth, sleep, neurocognitive outcomes, and gut microbiome by 24 months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.